Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas M McCarty

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2012
Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicityLucia E Rosas, Jessica L Grieves, Kimberly Zaraspe, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2018
Targeting Root Cause by Systemic scAAV9-h<i>IDS</i> Gene Delivery: Functional Correction and Reversal of Severe MPS II in MiceHaiyan Fu, Kim Zaraspe, Naoko Murakami, et al.
Molecular Therapy. Methods & Clinical Development|June 23, 2016
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene deliveryHaiyan Fu, Marcela P Cataldi, Tierra A Ware, et al.
Metabolic Brain Disease|January 13, 2011
Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB miceDouglas M McCarty, Julianne DiRosario, Kadra Gulaid, et al.
Human Gene Therapy. Clinical Development|October 25, 2017
Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene TherapyHaiyan Fu, Aaron S Meadows, Ricardo J Pineda, et al.
Journal of Neuroscience Research|October 28, 2008
Innate and adaptive immune activation in the brain of MPS IIIB mouse modelJulianne DiRosario, Erin Divers, Chuansong Wang, et al.
Molecular Pain|February 1, 2006
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in ratsBenjamin Storek, Nina M Harder, Michaela S Banck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 17, 2015
Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA miceF Jason Duncan, Bartholomew J Naughton, Kimberly Zaraspe, et al.
Journal of Alzheimer'S Disease : JAD|August 1, 2014
Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's diseaseBartholomew J Naughton, F Jason Duncan, Darren A Murrey, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2012
Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicityLucia E Rosas, Jessica L Grieves, Kimberly Zaraspe, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2018
Targeting Root Cause by Systemic scAAV9-h<i>IDS</i> Gene Delivery: Functional Correction and Reversal of Severe MPS II in MiceHaiyan Fu, Kim Zaraspe, Naoko Murakami, et al.
Molecular Therapy. Methods & Clinical Development|June 23, 2016
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene deliveryHaiyan Fu, Marcela P Cataldi, Tierra A Ware, et al.
Metabolic Brain Disease|January 13, 2011
Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB miceDouglas M McCarty, Julianne DiRosario, Kadra Gulaid, et al.
Human Gene Therapy. Clinical Development|October 25, 2017
Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene TherapyHaiyan Fu, Aaron S Meadows, Ricardo J Pineda, et al.
Journal of Neuroscience Research|October 28, 2008
Innate and adaptive immune activation in the brain of MPS IIIB mouse modelJulianne DiRosario, Erin Divers, Chuansong Wang, et al.
Molecular Pain|February 1, 2006
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in ratsBenjamin Storek, Nina M Harder, Michaela S Banck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 17, 2015
Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA miceF Jason Duncan, Bartholomew J Naughton, Kimberly Zaraspe, et al.
Journal of Alzheimer'S Disease : JAD|August 1, 2014
Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's diseaseBartholomew J Naughton, F Jason Duncan, Darren A Murrey, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Pageof 4